Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By Means Of An Open House Model To The Active Ingredient Ustekinumab (Atc Code According To Who: L04Ac05)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 109177459

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements according to Section 130a (8) SGB V via medicinal products with the active ingredient Ustekinumab (ATC code according to WHO: L04AC05). The contract i s concluded as part of a so-called open house model, i.e. h. A conclusion of a contract is open to all interested pharmaceutical companies within the period of participation, provided that they meet and accept the participation requirements. As a result, individual contract negotiations are not conducted and that there is no (delivery) exclusivity. It is pointed out that the acceptance of the acceptance is unknown, since this depends on the deman

Gt Ref Id - 109177459

Deadline - Jul 31, 2026